Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Rochester, Minnesota 14 trials found
New Search
Filter
Trial Phase
Study Type
Multi-Cancer Detection Observational Cohort Study
N/AOBSERVATIONAL Scottsdale, Arizona +2 more
RECRUITING
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
PHASE1INTERVENTIONAL Rochester, Minnesota
RECRUITING
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
NAINTERVENTIONAL Rochester, Minnesota
RECRUITING
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
N/AOBSERVATIONAL Jacksonville, Florida +1 more
RECRUITING
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Statins to Prevent Cancer Associated Blood Clots
PHASE4INTERVENTIONAL Irvine, California +4 more
RECRUITING
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Jacksonville, Florida +3 more
RECRUITING
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
PHASE2INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
PHASE2INTERVENTIONAL Rochester, Minnesota
RECRUITING
Filter Trials
Trial Phase
Study Type